Abstract:Shao-Chun Wu, 1, &ast Cheng-Shyuan Rau, 2, &ast Pao-Jen Kuo, 3 Fu-Yuan Shih, 2 Hui-Ping Lin, 3 Yi-Chan Wu, 3 Ting-Min Hsieh, 4 Hang-Tsung Liu, 4 Ching-Hua Hsieh 3 1 Department of Anesthesiology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan; 2 Department of Neurosurgery, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan; 3 Department of Plastic Surgery, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan; 4 Department of Trauma Surgery, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan &astThese authors contributed equally to this work Correspondence: Ching-Hua Hsieh Department of Plastic Surgery, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, No. 123, Ta-Pei Road, Niao-Song District, Kaohsiung, 833, Taiwan Tel +886-7-7327476 Fax +886-7-3450431 Email Purpose: Severe trauma may lead to the systemic release of inflammatory mediators into the circulation with profound acute-phase responses; however, the understanding of the expression of these mediators remains limited. This study aimed to characterize the alterations in the expression of circulating acute-phase proteins, cytokines, and checkpoint proteins in patients with severe trauma injuries. Patients and Methods: The study population included trauma patients in the intensive care unit (ICU) with an injury severity score equal to or greater than 16 and who had used a ventilator for 48 hours. A total of 12 female and 28 male patients were recruited for the study; six patients died and 34 survived. Blood samples collected at acute stages were compared with those drawn at the subacute stage, the time when the patients were discharged from the ICU, or before the discharge of the patients from the hospital. Results: The study identified that the expression of acute-phase proteins, such as alpha-1-acid glycoprotein and C-reactive protein, and cytokines, including granulocyte colony-stimulating factor, interleukin-6, and interleukin-1 receptor antagonist, was elevated in the circulation after severe trauma. In contrast, the levels of acute-phase proteins, such as alpha-2-macroglobulin, serum amyloid P, and von Willebrand factor, and cytokines, including interleukin-4 and interferon gamma-induced protein 10, were reduced. However, there were no significant differences in the expression of checkpoint proteins in the circulation. Conclusion: The dysregulated proteins identified in this study may serve as potential therapeutic targets or biomarkers for treating patients with severe trauma. However, the related biological functions of these dysregulated factors require further investigation to validate their functions. Keywords: circulation, inflammatory reaction, biomarkers, severe trauma, critical illness Tissue damage during trauma results in the release of damage-associated molecular patterns and other mediators at the site of injury. Such mediators disrupt the homeostasis of the immune system and may activate various immune responses with downstream complications, such as infections and sepsis. To adapt and survive, hosts react with a set of mechanisms aimed at restoring the equilibrium of the immune system. The acute phase response of the innate immune system plays a crucial role in trauma 1 and is demonstrated by the change in circulating acute-phase protein levels; this may explain the differences in susceptibility to infectious organisms. 2 The systemic acute phase response might impair host defense against P. aeruginosa pneumonia 3 and inhibit the local inflammatory response to A. baumannii pneumonia, thereby facilitating the outgrowth of bacteria. 4 Trauma leads to the systemic release of inflammatory mediators into the circulation from norepinephrine terminals in peripheral organs such as the liver, spleen, and lymphocytes. 5 , 6 These cytokines from severely injured trauma patients systemically regulate cytokine expression in the bone marrow stroma, 7 resulting in the prolonged mobilization of hematopoietic progenitor cells from the bone marrow stroma 8 into the circulation and to the site of injury. 9–11 These cytok -Abstract Truncated-

[Dynamic Change in Interleukin-18 and Its Relationships with Multiple Organ Dysfunction Syndrome].

Dynamic Changes of Circulating T-Helper Cell Subsets Following Severe Thoracic Trauma

Peripheral Inflammatory Markers in Patients with Prolonged Disorder of Consciousness after Severe Traumatic Brain Injury.

Detection of serum interleukin-6 in multiple trauma patients:Analysis of 42 cases

Clinical Significance of Shift of Plasma IFN-γ、IL-4 Cytokines in Patients after Trauma

Changes of Interleukin 2 and Soluble Interleukin 2 Receptor Serum Level and Multiple Organ Dysfunction Syndrome in Severely Traumatic Patients

Clinical significance of serum interleukin-18 (IL-18) and matrix metalloproteinase-(MMP-9) on acute coronary syndrome

Relationship Between Serum Concentrations of IL-18, IL-10, IL-6 and Acute Coronary Syndrome

Levels of antibodies to endotoxin and cytokine release in patients with severe trauma: does posttraumatic dysergy contribute to organ failure?

Expression Patterns of Plasma Von Willebrand Factor and Serum Interleukin-8 in Patients with Early-Stage Severe Pulmonary Contusion

Dynamic Change in Interleukin18 Mrna Expression and Its Implication in Thermalinjured Rats

High Serum Interleukin-6 Concentration Upon Admission is Predictive of Disease Severity in Paediatric Trauma Patients.

Serum levels of HMGB-1 and organ dysfunction and death in patients with multiple trauma

The Changes and Clinical Significance of Detection of Serun Soluble Interleukin-2 Receptor in Patients from Mechanical Trauma

Serum Interleukin-6 as an Early Indicator of Trauma Complications

The Expression of Von Willebrand Factor and Interleukin-8 in Severe Pulmonary Contusion Patients

[Study on High Mobility Group-1 Protein in Patients with Multiple Trauma].

Activation and Clinical Significance of p38 MAPK Signaling Pathway in Patients With Severe Trauma

Matrix metalloproteinase-9 as new biomarkers of severity in multiple organ dysfunction syndrome caused by trauma and infection

Protective/reparative cytokines are suppressed at high injury severity in human trauma

Profiling the Expression of Circulating Acute-Phase Proteins, Cytokines, and Checkpoint Proteins in Patients with Severe Trauma: A Pilot Study